Table 4.
Statistically Significant Associations between miRNAs and Clinicopathologic Parameters (Multivariate Regression Analysis)
| miRNA | Clinicopathologic parameter | p-Value | Relationship |
|---|---|---|---|
| miR-155 | Age | 1.14E-04 | Higher expression levels are associated with increasing age |
| MSI-L | 7.19E-03 | Lower expression levels are associated with MSI-L status | |
| MSS | 2.03E-03 | Lower expression levels are associated with MSS status | |
| miR-223 | Age | 5.50E-04 | Higher expression levels are associated with increasing age |
| HNPCC | 2.08E-02 | Higher expression levels are associated with HNPCC | |
| miR-31 | Side | 6.61E-04 | Higher expression levels are associated with tumors on the right side |
| HNPCC | 1.63E-02 | Higher expression levels are associated with HNPCC | |
| miR-196a | MSS | 1.24E-03 | Higher expression levels are associated with MSS status |
| miR-26b | MSS | 1.24E-03 | Lower expression levels are associated with stability. |
| let-7a | MSS | 1.12E-02 | Lower expression levels are associated with MSS status |
| miR-92 | MSI-L | 1.35E-02 | Higher expression levels are associated with MSI-L status |
| MSS | 2.50E-02 | Lower expression levels are associated with MSS status | |
| miR-192 | Side | 1.48E-02 | Lower expression levels are associated with tumors on the right side |
| miR-135a | Age | 1.42E-02 | Lower expression levels are associated with increasing age |